China Shineway Pharmaceutical Group Limited (SEHK: 2877)
Health Care · Pharmaceuticals · CN
HK$7.43
+1.16% today · -12.9% 1Y
China Shineway Pharmaceutical Group Limited (SEHK: 2877) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $714.72M and employs 2,822 people.
Over the last twelve months the share price has lost 12.9%, trading between 7.12 and 10.47.
Tweenvest scores China Shineway Pharmaceutical Group Limited across four factors: quality 89/100, value 63/100, growth 28/100, dividend 93/100. Its strongest factor is dividend.
2877 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $714.72M
- Revenue (TTM)
- $392.15M
- P/E
- 6.04
- EPS
- 1.06
- Dividend yield
- 19.61%
- Beta (5Y)
- 0.68
- 52-week high
- HK$10.47
- 52-week low
- HK$7.12
- Avg volume (3M)
- —
- Shares outstanding
- 755.40M
- Employees
- 2,822
- Next earnings
- —
About China Shineway Pharmaceutical Group Limited
As an investment holding enterprise, China Shineway Pharmaceutical Group Limited is dedicated to the development, production, and sale of traditional Chinese medicines throughout the People's Republic of China and Hong Kong. Its extensive product range includes modern Chinese pharmaceuticals delivered as soft capsules, granular preparations, and injectable forms, alongside specialized Traditional Chinese Medicine (TCM) Formula Granules. These offerings cater to a broad spectrum of therapeutic needs, such as cardiovascular and cerebrovascular health, anti-viral applications, orthopedic conditions, pediatric ailments, gynecological care, and gastrointestinal issues. Furthermore, the company is involved in the trading of agricultural commodities. Founded in 2004, its headquarters are situated in Shijiazhuang, PRC, and it functions as a subsidiary of Forway Investment Limited.
- ISIN
- KYG2110P1000
- Founded
- 2002
- Listed since
- Dec 2, 2004
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Oneness Biotech Co., Ltd.TPEX: 4743 | $721.31M | NT$48.10 | +2.01% |
| Collegium Pharmaceutical, Inc.NasdaqGS: COLL | $719.15M | $22.04 | -0.23% |
| Tibet Duo Rui Pharmaceutical Co., Ltd.SZSE: 301075 | $716.02M | CN¥59.95 | -5.10% |
| Fuan Pharmaceutical (Group) Co., Ltd.SZSE: 300194 | $715.81M | CN¥4.03 | +3.60% |
| Nxera Pharma Co., Ltd.TSE: 4565 | $710.97M | ¥1,232.00 | +0.98% |
| Bliss GVS Pharma LimitedBSE: 506197 | $708.15M | Rs644.55 | -5.80% |
| Supriya Lifescience LimitedNSEI: SUPRIYA | $704.91M | Rs847.65 | -8.95% |
| Sanofi India LimitedBSE: 500674 | $700.94M | Rs2,945.55 | -2.84% |
Figures last refreshed Oct 11, 2026.